Cargando…
The role of brain gaseous neurotransmitters in anxiety
Although anxiety is perhaps one of the most significant current medical and social problems, the neurochemical mechanistic background of this common condition remains to be fully understood. Multifunctional regulatory gasotransmitters are novel, atypical inorganic factors of the brain that are invol...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994231/ https://www.ncbi.nlm.nih.gov/pubmed/33713315 http://dx.doi.org/10.1007/s43440-021-00242-2 |
_version_ | 1783669710461599744 |
---|---|
author | Pałasz, Artur Menezes, Itiana Castro Worthington, John J. |
author_facet | Pałasz, Artur Menezes, Itiana Castro Worthington, John J. |
author_sort | Pałasz, Artur |
collection | PubMed |
description | Although anxiety is perhaps one of the most significant current medical and social problems, the neurochemical mechanistic background of this common condition remains to be fully understood. Multifunctional regulatory gasotransmitters are novel, atypical inorganic factors of the brain that are involved in the mechanisms of anxiety responses. Nitric oxide (NO) signaling shows ambiguous action in animal models of anxiety, while NO donors exert anxiogenic or anxiolytic effect depending on their chemical structure, dose, treatment schedule and gas release rapidity. The majority of NO synthase inhibitors act as a relatively potent axiolytic agents, while hydrogen sulfide (H(2)S) and carbon monoxide (CO) delivered experimentally in the form of “slow” or “fast” releasing donors have recently been considered as anxiolytic neurotransmitters. In this comprehensive review we critically summarize the literature regarding the intriguing roles of NO, H(2)S and CO in the neuromolecular mechanisms of anxiety in the context of their putative, yet promising therapeutic application. A possible mechanism of gasotransmitter action at the level of anxiety-related synaptic transmission is also presented. Brain gasesous neuromediators urgently require further wide ranging studies to clarify their potential value for the current neuropharmacology of anxiety disorders. |
format | Online Article Text |
id | pubmed-7994231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-79942312021-04-16 The role of brain gaseous neurotransmitters in anxiety Pałasz, Artur Menezes, Itiana Castro Worthington, John J. Pharmacol Rep Review Although anxiety is perhaps one of the most significant current medical and social problems, the neurochemical mechanistic background of this common condition remains to be fully understood. Multifunctional regulatory gasotransmitters are novel, atypical inorganic factors of the brain that are involved in the mechanisms of anxiety responses. Nitric oxide (NO) signaling shows ambiguous action in animal models of anxiety, while NO donors exert anxiogenic or anxiolytic effect depending on their chemical structure, dose, treatment schedule and gas release rapidity. The majority of NO synthase inhibitors act as a relatively potent axiolytic agents, while hydrogen sulfide (H(2)S) and carbon monoxide (CO) delivered experimentally in the form of “slow” or “fast” releasing donors have recently been considered as anxiolytic neurotransmitters. In this comprehensive review we critically summarize the literature regarding the intriguing roles of NO, H(2)S and CO in the neuromolecular mechanisms of anxiety in the context of their putative, yet promising therapeutic application. A possible mechanism of gasotransmitter action at the level of anxiety-related synaptic transmission is also presented. Brain gasesous neuromediators urgently require further wide ranging studies to clarify their potential value for the current neuropharmacology of anxiety disorders. Springer International Publishing 2021-03-13 2021 /pmc/articles/PMC7994231/ /pubmed/33713315 http://dx.doi.org/10.1007/s43440-021-00242-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Pałasz, Artur Menezes, Itiana Castro Worthington, John J. The role of brain gaseous neurotransmitters in anxiety |
title | The role of brain gaseous neurotransmitters in anxiety |
title_full | The role of brain gaseous neurotransmitters in anxiety |
title_fullStr | The role of brain gaseous neurotransmitters in anxiety |
title_full_unstemmed | The role of brain gaseous neurotransmitters in anxiety |
title_short | The role of brain gaseous neurotransmitters in anxiety |
title_sort | role of brain gaseous neurotransmitters in anxiety |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994231/ https://www.ncbi.nlm.nih.gov/pubmed/33713315 http://dx.doi.org/10.1007/s43440-021-00242-2 |
work_keys_str_mv | AT pałaszartur theroleofbraingaseousneurotransmittersinanxiety AT menezesitianacastro theroleofbraingaseousneurotransmittersinanxiety AT worthingtonjohnj theroleofbraingaseousneurotransmittersinanxiety AT pałaszartur roleofbraingaseousneurotransmittersinanxiety AT menezesitianacastro roleofbraingaseousneurotransmittersinanxiety AT worthingtonjohnj roleofbraingaseousneurotransmittersinanxiety |